D322-0530 Screening compound: 4-(2-methoxybenzoyl)-2-(propan-2-yl)-4a,5,6,7,8,8a-hexahydro-4H-spiro[[1,2,4]triazolo[3,2-b]quinazoline-9,1'-cyclohexane]

D322-0530 Screening compound: 4-(2-methoxybenzoyl)-2-(propan-2-yl)-4a,5,6,7,8,8a-hexahydro-4H-spiro[[1,2,4]triazolo[3,2-b]quinazoline-9,1'-cyclohexane]
D322-0530 Screening compound: 4-(2-methoxybenzoyl)-2-(propan-2-yl)-4a,5,6,7,8,8a-hexahydro-4H-spiro[[1,2,4]triazolo[3,2-b]quinazoline-9,1'-cyclohexane] alternative view

Chemical Structure Depiction of ChemDiv screening compound D322-0530
4-(2-methoxybenzoyl)-2-(propan-2-yl)-4a,5,6,7,8,8a-hexahydro-4H-spiro[[1,2,4]triazolo[3,2-b]quinazoline-9,1'-cyclohexane]

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D322-0530

Molecular Formula

C25H34N4O2 (C25 H34 N4 O2)

Compound Name

4-(2-methoxybenzoyl)-2-(propan-2-yl)-4a,5,6,7,8,8a-hexahydro-4H-spiro[[1,2,4]triazolo[3,2-b]quinazoline-9,1'-cyclohexane]

IUPAC name

(4aS8aR)-4-(2-methoxybenzoyl)-2-(propan-2-yl)-4a56788a-hexahydro-4H-spiro[[124]triazolo[32-b]quinazoline-91'-cyclohexane]

SMILES

CC(C)c1nn(C2(CCCCC2)[C@H](CCCC2)[C@H]2N2C(c(cccc3)c3OC)=O)c2n1

InChI

InChI=1S/C25H34N4O2/c1-17(2)22-26-24-28(23(30)18-11-5-8-14-21(18)31-3)20-13-7-6-12-19(20)25(29(24)27-22)15-9-4-10-16-25/h5,8,11,14,17,19-20H,4,6-7,9-10,12-13,15-16H2,1-3H3/t19-,20-/m0/s1

InChI Key

OHLMTPMMNJVJHC-PMACEKPBSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

422.57

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.121

Distribution Coefficient, logD

5.121

Water Solubility, LogSw

-4.86

Polar Surface Area

45.518

Acid Dissociation Constant (pKa)

20.55

Base Dissociation Constant (pKb)

1.43

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

64.00

D322-0530 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with D322-0530 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D322-0530?
Check Price and Availability of D322-0530, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D322-0530 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D322-0530
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D322-0530
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D322-0530 available by request